drugset / Trial / NCT06624696

Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at Risk Undergoing Sevoflurane Anesthesia

NCT06624696

RandomizedParallel-groupQuadruple-blindPrevention

Summary

This randomized controlled study is to evaluate the effectiveness of inhaling penehyclidine hydrochloride in reducing perioperative respiratory adverse events in children at risk undergoing minor elective surgery.

Timeline

Start
2024-11-12
Primary completion
2026-08-31
Completion
2026-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Penehyclidine Small molecule 0.05 mg/kg Inhaled